PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

  • Kim A Papp
  • Bruce Strober
  • Matthias Augustin
  • Steve Calabro
  • Anil Londhe
  • Marc Chevrier
  • PSOLAR Investigators
  • Steering Committee

Abstract

Long-term observational studies can better characterize the impact of systemic agents on psoriasis.

Bibliographical data

Original languageEnglish
Article number10
Publication statusPublished - 2012
pubmed 23134986